Mivavotinib Completed Phase 1 Trials for Refractory Malignant Solid Neoplasm / Ovarian Carcinoma / Advanced Malignant Solid Tumor / Refractory Ovarian Carcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03756818TAK-659 and Paclitaxel in Treating Patients With Advanced Solid Tumors